(19)
(11) EP 4 473 018 A2

(12)

(88) Date of publication A3:
14.09.2023

(43) Date of publication:
11.12.2024 Bulletin 2024/50

(21) Application number: 23750472.5

(22) Date of filing: 03.02.2023
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61P 35/00(2006.01)
C07K 16/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2827; C07K 2317/21; C07K 2317/565; A61P 35/00; C07K 2317/92; C07K 2317/33; C07K 2317/94; C07K 2317/732; A61K 2039/505; C07K 2317/76
(86) International application number:
PCT/US2023/061996
(87) International publication number:
WO 2023/150724 (10.08.2023 Gazette 2023/32)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 04.02.2022 US 202263306938 P

(71) Applicant: Vivasor, Inc.
San Diego, CA 92121 (US)

(72) Inventors:
  • HERRMANN, Andreas
    San Diego, California 92121 (US)
  • BRESSON, Damien
    San Diego, California 92121 (US)
  • ZHOU, Heyue
    San Diego, California 92121 (US)
  • SHEN, Weiqun
    San Diego, California 92121 (US)

(74) Representative: Script Intellectual Property LLP 
Suite J, Anchor House School Close Chandlers Ford
Eastleigh, Hampshire SO53 4DY
Eastleigh, Hampshire SO53 4DY (GB)

   


(54) ANTIGEN BINDING PROTEINS THAT BIND B7-H3